Council for europe portal
Language : en Search
Choose language

Search

89 results
  • Press release 04 2020 - Pharmacopoeial Discussion Group (PDG) videoconference meeting - April 2020
    The Pharmacopoeial Discussion Group (PDG) held its interim videoconference on Thursday 12 March 2020. The PDG – which brings together the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP), with WHO (International Pharmacopoeia) as Observer, to discuss international harmonisation of quality standards – has now completed work on 28 of the 31 general chapters and 46 of the 60 excipient monographs on its current work programme.
  • Press release 03 2020 - “Meet the World Pharmacopoeias” Symposium - March 2020
    The EDQM organised the one-day “Meet the World Pharmacopoeias” Symposium on 20 February 2020 at the EDQM premises in Strasbourg, after the 11th International Meeting of World Pharmacopoeias (IMWP), which was also hosted at its premises.
  • Press release 02 2020 - International Meeting World Pharmacopoeias - February 2020
    At the 11th International Meeting of the World Pharmacopoeias (IMWP) co-hosted by the WHO and the EDQM in Strasbourg (France), national and regional pharmacopoeias brought forward initiatives to strengthen their co-operation as a way to improve public health outcomes for patients.
  • Press Release - European Paediatric Formulary goes live on 11 December 2019 - December 2019
    The EDQM is pleased to announce that the European Paediatric Formulary is now available free of charge on a dedicated online platform. This is a major achievement for the PaedForm Working Party and all the stakeholders involved, since it not only embodies several years’ work and dedication to the project, but feeds into the fundamental human right of equal access to quality healthcare.
  • Press release - Pharmacopoeial Discussion Group videoconference meeting - April 2019
    The Pharmacopoeial Discussion Group (PDG) held its interim videoconference on Wednesday 13 March 2019. The PDG, which brings together the European Pharmacopoeia (Ph. Eur.), Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP) with WHO (International Pharmacopoeia) as Observer, to discuss international harmonisation of quality standards, has now completed work on 28 of the 31 general chapters and 46 of the 60 excipient monographs on its current work programme.
  • Press release - Outcome of the 165th Session of the European Pharmacopoeia Commission - December 2019
    During its 165th session, held in Strasbourg on 26 and 27 November 2019, the European Pharmacopoeia (Ph. Eur.) Commission (re)appointed more than 850 experts to its current 21 groups of experts and 39 active working parties for a new term running from November 2019 to November 2022.
  • Press release - New secondary site of the EDQM: resilience and business continuity - November 2019
    The new secondary site of the EDQM, being opened and inaugurated on 15 November 2019, will enable the safe storage of contingency stocks of European Pharmacopoeia reference standards and ensure their distribution worldwide in the event of major incidents at its main site in Strasbourg.
  • Press Release - Pharmacopoeial Discussion Group achievements - October 2019
    The latest face-to-face meeting of the Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (Ph. Eur.), Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP)] was hosted by JP in Tokyo, Japan on 1-2 October 2019. WHO participated as observer. The PDG 30th Anniversary Symposium was also held on 3 October 2019.
  • Press release - New approach to extraneous agents testing of immunological veterinary medicinal products (IVMPs) - October 2019
    During its 164th session on 18 June 2019, the European Pharmacopoeia Commission adopted 43 texts related to its new approach to extraneous agents testing of immunological veterinary medicinal products (IVMPs). The new approach constitutes a move away from the description of detailed methods towards greater flexibility and allowing tailoring to individual product needs. From starting material to final product, users will now have to follow an overall risk-management approach to ensure they apply the best testing strategies in the context of a consistent manufacturing process.
  • Press Release - European Pharmacopeia 10th Edition: continuous updates to address new challenges - September 2019
    The newly released 10th Edition of the European Pharmacopoeia, contains 2 420 monographs and 373 general texts (including general monographs and methods of analysis), as well as around 2 780 descriptions of reagents. In total, 114 new monographs have been introduced*1, of these 17 concern active substances of high medical interest covering key therapeutic classes, such as antineoplastics, immunosuppressants, anti-arrhythmics, anti-thrombotics, antiretrovirals or analgesics; and 7 monographs concern finished products containing chemically defined active substances.